Predict your next investment

New England Biolabs company logo
Corporation
HEALTHCARE | Biotechnology
neb.com

See what CB Insights has to offer

Founded Year

1974

Stage

Grant | Alive

Total Raised

$150K

Last Raised

$150K | 11 yrs ago

About New England Biolabs

New England Biolabs (NEB) specializes in the discovery and production of enzymes for molecular biology applications and now offers the largest selection of recombinant and native enzymes for genomic research. NEB continues to expand its product offerings into areas related to PCR and qPCR, gene expression, sample preparation for next generation sequencing, synthetic biology, glycobiology, epigenetics and RNA analysis. Additionally, NEB is focused on strengthening alliances that enable new technologies to reach key market sectors, including molecular diagnostics development. New England Biolabs is a privately held company, headquartered in Ipswich, MA, and has extensive worldwide distribution through a network of exclusive distributors, agents and seven subsidiaries located in Canada, China, France, Germany, Japan, Singapore and the UK.

New England Biolabs Headquarter Location

240 County Road

Ipswich, Massachusetts, 01938,

United States

800-632-5227

Latest New England Biolabs News

22:15 ET USD 13.09 bn growth in Molecular Biology Enzymes, Kits, and Reagents Market | Evolving Opportunities with Agilent Techn...

Nov 30, 2021

| Evolving Opportunities with Agilent Technologies Inc. & F. Hoffmann-La Roche Ltd. | 17000 + Technavio Reports News provided by Share this article Share this article NEW YORK, Nov. 29, 2021 /PRNewswire/ -- The " Molecular Biology Enzymes, Kits, and Reagents Market - Competitive Analysis, Drivers, Challenges & Five Force Analysis " report has been added to Technavio's offering. The molecular biology enzymes, kits, and reagents market value is set to grow by USD 13.09 billion, progressing at a CAGR of 14.61% from 2020 to 2025. For more insights on the Molecular Biology Enzymes, Kits, and Reagents Market - Download a free sample now! Attractive Opportunities in Molecular Biology Enzymes, Kits, and Reagents Market by End-user and Geography - Forecast and Analysis 2021-2025 39% of the market's growth will originate from North America. The US is a key market for molecular biology enzymes, kits, and reagents in the region. The rising incidence of infectious diseases and genetic disorders will facilitate the molecular biology enzymes, kits, and reagents market growth in North America. The report offers an up-to-date analysis of the geographical composition of the market, competitive intelligence, and regional opportunities in store for vendors. Market Dynamics Factors such as increased use of proteins and reagents in biotechnology and pharmaceutical companies and the rising number of genome projects will drive the growth of the Molecular Biology Enzymes, Kits, And Reagents Market. However, privacy issues concerning data leakage of genetic information might hamper market growth. The holistic analysis of the drivers will help in predicting end goals and refining marketing strategies to gain a competitive edge. Company Profiles The molecular biology enzymes, kits, and reagents market are fragmented and the vendors are deploying various organic and inorganic growth strategies to compete in the market. The molecular biology enzymes, kits, and reagents market report provide complete insights on key vendors including Agilent Technologies Inc., F. Hoffmann-La Roche Ltd., Illumina Inc., Merck KGaA, New England Biolabs Inc., Promega Corp., QIAGEN NV, Rockland Immunochemicals Inc., Takara Bio Inc., and Thermo Fisher Scientific Inc. Few Companies with Key Offerings Agilent Technologies Inc.- The company offers polymerase chain reaction (PCR) enzymes and reagents, inhibitors, and kits for various applications such as reverse transcriptase cloning, cDNA from an RNA template, and high-fidelity cloning F. Hoffmann-La Roche Ltd. - The company offers a range of molecular biology enzymes, kits, and reagents under its subsidiary Kapa Biosystems, Inc. Illumina Inc. - The company offers a range of common molecular biology reagents such as ribosomal RNA removal reagents, DNA/RNA extraction kits, PCR reagents, and others. Competitive Analysis The report includes the competitive analysis, a proprietary tool to analyze and evaluate the position of companies based on their industry position score and market performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc. Market Segmentation By End-user, the market is classified into biotechnology and pharmaceutical companies, hospitals and diagnostic centers, and academic institutes and research organizations. The molecular biology enzymes, kits, and reagents market share growth by the biotechnology and pharmaceutical companies segment has been significant By Geography, the market is classified as North America, Europe, Asia, and ROW. North America will have the largest share of the market. Related Reports - Metabolomics Market -The metabolomics market share should rise by USD 1.99 billion from 2021 to 2025 at a CAGR of 11.84%. Download a free sample now! Immunoprotein Diagnostic Testing Market  - The immunoprotein diagnostic testing market has the potential to grow by USD 11.48 billion during 2021-2025, and the market's growth momentum will accelerate at a CAGR of 8.64%. Download a free sample now! Molecular Biology Enzymes, Kits, And Reagents Market Scope Report Coverage Companies profiled Agilent Technologies Inc., F. Hoffmann-La Roche Ltd., Illumina Inc., Merck KGaA, New England Biolabs Inc., Promega Corp., QIAGEN NV, Rockland Immunochemicals Inc.  , Takara Bio Inc., and Thermo Fisher Scientific Inc. Market Dynamics Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, market condition analysis for the forecast period Customization purview If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. About Us Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios. Contact

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Research containing New England Biolabs

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned New England Biolabs in 2 CB Insights research briefs, most recently on Nov 23, 2021.

Expert Collections containing New England Biolabs

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

New England Biolabs is included in 1 Expert Collection, including Synthetic Biology.

S

Synthetic Biology

235 items

Companies involved in design and development of new biological parts, devices, and systems; as well as the re-design of existing biological systems.

New England Biolabs Patents

New England Biolabs has filed 190 patents.

The 3 most popular patent topics include:

  • Molecular biology
  • Biotechnology
  • Genetics
patents chart

Application Date

Grant Date

Title

Related Topics

Status

5/12/2017

11/2/2021

Molecular biology, DNA replication, Biotechnology, DNA, Molecular biology techniques

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

5/12/2017

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

11/2/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Molecular biology, DNA replication, Biotechnology, DNA, Molecular biology techniques

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

New England Biolabs Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

New England Biolabs Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.